Home › Markets › Health Care › BSX

Boston Scientific Corporation (BSX)

BSX trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$43.31
-1.21% on the day
Market cap
$62.8B
Large cap
Revenue · 2025
$20.1B
+19.9% on 2024
Net income · 2025
Net income not in SEC XBRL data
0.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerBSX on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000885725
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$20.1B
Net incomeNot in SEC XBRL data
Operating income$3.6B
Net margin0.0%
Operating margin18.0%
Revenue growth+19.9%
Cash$2.0B
Total assets$43.7B
P/E (computed)Net income was not positive
P/S (computed)3.1×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-04-01
Latest annual report10-K2026-02-17
Latest quarterly / interim10-Q2026-08-03
Latest current report8-K2026-10-07
Latest proxyDEFA14A2026-03-18

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.4%
1 month-2.0%
3 months-3.6%
Year to date-54.9%
1 year-54.7%
From 52-week high-59.0%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
BDXBecton Dickinson and Company$187.37-0.81%$51.0B
MDLNMedline Inc.$35.70-0.17%$46.9B
MMM3M Company$162.77+1.17%$83.9B
SYKStryker Corporation$282.55-0.02%$108.4B
RMDResMed Inc.$235.04+0.19%$33.1B
DXCMDexCom Inc.$85.06-1.00%$32.1B
WSTWest Pharmaceutical Services Inc.$371.82+1.15%$26.2B
SOLVSolventum Corporation$86.30+1.16%$14.7B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier